Why Due Diligence Kills More University Spinouts Than Bad Science

Most university spinouts die during due diligence. Not because the science is bad—the technology often works brilliantly in the lab. They die because nobody prepared them for what investors actually want to see.

Photo by Pixabay on Pexels.

I've watched dozens of promising spinouts crash into the same wall. The founding team walks into their first serious VC meeting armed with Nature publications, provisional patents, and lab data that would make any professor weep with joy. Six months later? Dead in the water.

The problem isn't the science. It's that academic inventors fundamentally misunderstand what due diligence tests for.

What Academics Think VCs Want to See

Professors approach fundraising like they're defending their thesis. They prepare extensive technical presentations showing:

• Peer-reviewed publications proving the science works
• Detailed experimental protocols and reproducibility data
• Intellectual property landscapes and freedom-to-operate analyses
• Academic collaborations and advisory relationships

This makes perfect sense in academia, where technical rigor is everything. But VCs aren't trying to replicate your experiments.

What VCs Actually Interrogate During Due Diligence

While founders are polishing their technical slides, investors are digging into completely different questions:

Market validation beyond the lab. Can you name three potential customers who have a real problem your technology solves? Not theoretical applications—actual companies with budgets.

Regulatory pathway and timeline. If you need FDA approval, what's your 510(k) strategy? How long will clinical trials take? What happens if the regulatory landscape shifts?

Manufacturing and scale economics. Your process works beautifully at lab scale. What breaks when you try to make 10,000 units? What about 100,000?

Competitive response. When you succeed, how will incumbent players react? Can they build around your patents or simply acquire your future competitors?

These aren't technical questions. They're business questions that most academic founders have never seriously considered.

graph TD
    A[Academic Focus] --> B{Due Diligence}
    C[VC Focus] --> B
    B --> D[Technical Merit]
    B --> E[Market Validation]
    B --> F[Business Model]
    B --> G[Competitive Dynamics]
    A --> D
    C --> E
    C --> F
    C --> G

The Preparation Gap That Kills Deals

University tech transfer offices make this worse. They focus almost entirely on IP protection and licensing terms. Nobody teaches spinout founders how to build a customer development process or model unit economics.

The result? Founders spend months preparing for the wrong exam. When VCs start probing market assumptions, they discover the team has never talked to a potential customer outside of academic conferences. When investors ask about manufacturing costs, they get back-of-the-envelope calculations based on lab reagent prices.

This isn't ignorance—it's misaligned preparation. Academic founders are incredibly smart, but they're optimizing for the wrong evaluation criteria.

Three Questions That Expose the Gap Early

Before you pitch any serious investor, pressure-test your startup with these questions:

Who is your third customer? Not your first—every founder has a story about their ideal early adopter. Your third customer reveals whether you have a scalable market or just one lucky relationship.

What's your customer acquisition cost in Year Three? Early customers might find you through academic networks or pilot programs. How will you reach mainstream buyers who've never heard of your professor?

Where does your business model break? At what volume, price point, or competitive pressure does your current plan stop working? What's your backup strategy?

If you can't answer these questions with specifics, you're not ready for institutional investors. You'll waste months in due diligence processes that go nowhere.

Building Due Diligence Readiness Into University Programs

Tech transfer offices could fix this by changing how they prepare spinouts. Instead of focusing purely on IP strategy, they should require market validation before licensing deals close.

Some forward-thinking universities are already doing this. They're embedding customer development into their entrepreneur-in-residence programs and requiring business model validation alongside technical milestones.

The science coming out of universities is extraordinary. But without proper preparation for the business side of due diligence, too many breakthrough technologies never make it to market. That's a waste everyone should want to fix.